急性胰腺炎中 microRNAs 的新挑战:进展与治疗。

New challenges for microRNAs in acute pancreatitis: progress and treatment.

机构信息

The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, China.

Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, Gansu, China.

出版信息

J Transl Med. 2022 May 4;20(1):192. doi: 10.1186/s12967-022-03338-2.

Abstract

Acute pancreatitis (AP) is a common clinical abdominal emergency, with a high and increasing incidence each year. Severe AP can easily cause systemic inflammatory response syndrome, multiple organ dysfunction and other complications, leading to higher hospitalization rates and mortality. Currently, there is no specific treatment for AP. Thus, we still need to understand the exact AP pathogenesis to effectively cure AP. With the rise of transcriptomics, RNA molecules, such as microRNAs (miRNAs) transcribed from nonprotein-coding regions of biological genomes, have been found to be of great significance in the regulation of gene expression and to be involved in the occurrence and development of many diseases. Increasing evidence has shown that miRNAs, as regulatory RNAs, can regulate pancreatic acinar necrosis and apoptosis and local and systemic inflammation and play an important role in the development and thus potentially the diagnosis and treatment of AP. Therefore, here, the current research on the relationship between miRNAs and AP is reviewed.

摘要

急性胰腺炎(AP)是一种常见的临床腹部急症,其发病率每年都在升高。重症 AP 容易引起全身炎症反应综合征、多器官功能障碍等并发症,导致住院率和死亡率升高。目前,AP 尚无特异性治疗方法。因此,我们仍需要深入了解 AP 的发病机制,从而有效治疗 AP。随着转录组学的兴起,人们发现生物基因组中非蛋白编码区转录的 RNA 分子,如 microRNAs(miRNAs),在基因表达调控中具有重要意义,并参与多种疾病的发生和发展。越来越多的证据表明,miRNAs 作为调节性 RNA,可以调节胰腺腺泡细胞坏死和凋亡以及局部和全身炎症,并在 AP 的发展中发挥重要作用,因此具有潜在的诊断和治疗作用。因此,本文就 miRNAs 与 AP 的关系研究进展作一综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9066850/a782045dc91a/12967_2022_3338_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索